Why Seatrium stock is down today: SGX:5E2 slides 3% as tariff jitters hit Asia
19 January 2026
1 min read

Why Seatrium stock is down today: SGX:5E2 slides 3% as tariff jitters hit Asia

Singapore, Jan 19, 2026, 15:05 (SGT) — Regular session

Shares of Seatrium Limited (SGX:5E2) slipped about 3% during Monday’s afternoon trading, weighed down by a broader risk-off sentiment across Asia. By 2:50 p.m. SGT, the stock was down 3.1%, trading at S$2.17. 1

The decline stood out, hitting a cyclical stock that investors often track for signals on project execution and risk appetite. Singapore’s Straits Times Index dropped 0.5% by 1:50 p.m., dragged lower alongside broad losses across Asia as new tariff threats from Washington rattled markets. 2

Seatrium’s short-term swings tend to get amplified during volatile stretches. Offshore and marine contractors can act like macro stocks, even when their next big update is still weeks away.

Seatrium closed Monday at S$2.24, having traded in a range from S$2.16 to S$2.23 during the session. About 12.35 million shares changed hands. The stock has swung between S$1.62 and S$2.60 over the past 52 weeks. 3

Asia’s risk appetite took a hit after U.S. President Donald Trump threatened extra tariffs on eight European nations over Greenland purchase talks falling through. George Saravelos, Deutsche Bank’s global head of FX research, described it as “a weaponisation of capital rather than trade flows.” 4

Oil gave energy stocks a mixed message. Brent crude inched toward $64 a barrel. IG market analyst Tony Sycamore said the recent pullback came from a rapid unwinding of the “Iran premium”—the extra cost traders factor in for potential supply disruptions. 5

Seatrium’s business depends on lengthy project timelines, making daily market sentiment more influential than recent contract numbers. Traders are zeroing in on whether offshore spending holds steady and if offshore wind developments keep progressing, particularly in the U.S.

The risks are glaring. In October, Maersk canceled a $475 million contract for a nearly finished wind turbine installation vessel, citing “delays and related construction issues.” Seatrium replied that it is exploring its options, including possible legal action. 6

The downside is obvious: delays or weaker customer finances might squeeze contractors’ margins and working capital long before revenues feel the impact. U.S. offshore wind has also run into policy and permitting hurdles that can throw off delivery timelines.

Monday’s decline wasn’t driven by any single company news. Rather, it seemed investors were retreating, rattled by heavy macroeconomic headlines as the broader market turned less tolerant.

Investors have marked late February for important news. Per Investing.com, Seatrium is set to release its earnings on Feb. 20.

Seatrium confirmed delivery of a wind turbine installation vessel for Maersk Offshore Wind’s affiliate Phoenix II by Feb. 28, stemming from an earlier dispute. Maersk will pay the remaining $360 million of the $475 million contract once the vessel arrives, with $250 million structured as an interest-bearing credit over up to 10 years, according to The Business Times. Citi analyst Luis Hilado said the market reacted “positively,” as this clears a legal overhang and removes uncertainty tied to ongoing litigation. 7

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Yangzijiang Shipbuilding stock slips on SGX as risk-off mood bites; what to watch next
Previous Story

Yangzijiang Shipbuilding stock slips on SGX as risk-off mood bites; what to watch next

Genting Singapore stock slips as RWS CEO warns turnaround “takes time”
Next Story

Genting Singapore stock slips as RWS CEO warns turnaround “takes time”

Go toTop